Clinical and diagnostic aspects of Barth syndrome (X-linked cardiomyopathy);Aspekty kliniczne i diagnostyczne zespołu Bartha (kardiomiopatia sprzȩżona z chromosomem X)

Kardiologia Polska

Volumn 69, Issue 11, 2011, Pages 1177-1180

  Werner, Bozena ^a   Trubicka, Joanna ^b   Pronicka, Ewa ^b  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b CHILDREN'S MEMORIAL HEALTH INSTITUTE   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

BARTH SYNDROME; CLINICAL ASSESSMENT; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; REVIEW;

EID: 81555195447     PISSN: 00229032     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. Barth PG, Scholte HR, Berden JA et al. An X- linked mitochondrial disease affecting cardiac muscle, skeletal muscle and neutrophil leucocytes. J Neurol Sci, 1983; 62: 327-355. (Pubitemid 14176259)
2. Barth PG, Valianpour F, Bowen VM et al. X-linked cardioskeletal myopathy and neutropenia (Barth syndrome): An update. Am J Med Genet, 2004; 126A: 349-354. (Pubitemid 38541803)
3. Cantlay AM, Shokrollahi K, Allen JT et al. Genetic analysis of the G4.5 gene in families with suspected Barth syndrome. J Pediatr, 1999; 135: 311-315. (Pubitemid 30180503)
4. Steward CG, Newburry-Ecob RA, Hastings R et al. Barth syndrome: an X-linked cause of fetal cardiomyopathy and stillbirth. Prenat Diagn, 2010; 30: 979-976.
5. Sweeney RT, Davis GJ, Noonan JA. Cardiomyopathy of unknown etiology: Barth syndrome unrecognized. Congenit Heart Dis, 2008; 3: 443-448.
6. Szulik M, Lenarczyk A, Rycaj J et al. Kardiomiopatia ga̧bczasta u noworodka. Kardiol Pol, 2006; 64: 1422-1425.
7. Bione S, D'Adamo P, Maestrini E et al. A novel X-linked gene, G4.5. is responsible for Barth syndrome. Nat Genet, 1996; 12: 385-389. (Pubitemid 26106250)
8. Gebert N, Joshi AS, Kutik S et al. Mitochondrial cardiolipin involved in outer-membrane protein biosynthesis: implications for Barth syndrome. Curr Biol, 2009; 19: 2133-2139.
9. Editorial. A new look at cardiolipin. Bioch Biophys Acta, 2009; 1788: 1997-2002.
10. Johnston J, Kelley RI, Feigenbaum A et al. Mutation characterization and genotype-phenotype correlation in Barth syndrome. Am J Hum Gent, 1997; 61: 1053-1058. (Pubitemid 27492312)
11. Vreken P, Valianpour F, Nijtmans LG et al. Defective remodeling of cardiolipin and phosphatidylglycerol in Barth syndrome. Biochem Biophys Res Commun, 2000; 279: 378-382. (Pubitemid 32016725)
12. Lebiedzińska M, Karkucinska-Wieckowska A, Giorgi C et al. Oxidative stress-dependent p66She phosphorylation in skin fibroblasts of children with mitochondrial disorders. Biochem Biophys Acta, 2010; 1797: 952-960.
13. Brandner K, Mick DU, Frazier AE et al. Taz1, and outer mitochondrial membrane protein, affects stability and assembly of inner membrane protein complexes: implications for Barth syndrome. Mol Biol Cell, 2005; 16: 5202-5214. (Pubitemid 41566832)
14. Claypool SM. Cardiolipin, a critical determinant of mitochondrial carrier protein assembly and function. Bioch Biophys Acta, 2009; 1788: 2059-2068.
15. McKenzie M, Lazarou M, Thorburn DR, Ryan MT. Mitochondrial respiratory chain supercomplexes are destabilized in Barth syndrome patients. J Mol Biol, 2006; 361: 462-469. (Pubitemid 44118343)
16. Besley GTN, Lendon M, Broadhead DM et al. Mitochondrial complex deficiencies in a male with cardiomyopathy and 3 methylglutaconic aciduria. J Inher Metab Dis, 1995; 18: 221-223.
17. Christodoulou J, McInnes RR, Jay V et al. Barth Syndrome: Clinical observations and genetic linkage studies. Am J Med Gent, 1994; 50: 255-264. (Pubitemid 24109135)
18. Wortmann SB, Kluijtmans LA, Engelke UFH et al. The 3-methylglutaconic acidurias: what's new? J Inherit Metab Dis, 2010; DOI10.1007/s10545-010-9210-7.
19. Cižková A, Stranecký V, Mayr AM et al. TMEM70 mutations cause isolated ATP synthase deficiency and neonatal mitochondrial encephalocardiomyopathy. Nat Genet, 2008; 40: 1288-1290.
20. Mazzocco MM, Henry AE, Kelly RI. Barth syndrome is associated with a cognitive phenotype. J Dev Behav Pediatr, 2007; 28: 22-30. (Pubitemid 46423268)
21. Ting-Yu Y, Wuh-Liang H, Yin-Hsiu C et al. Acute metabolic decompensation and sudden death in Barth syndrome: report of a family and literature review. Eur J Pediatr, 2008; 167: 941-944.
22. Spencer CT, Byrne BJ, Gewitz MH et al. Ventricular arrhythmia in the X-linked cardiomyopathy Barth syndrome. Pediatr Cardiol, 2005; 26: 632-637. (Pubitemid 43015800)
23. Spencer CT, Bryant RM, Day J et al. Cardiac and clinical phenotype in Barth syndrome. Pediatrics, 2006; 118: e337-e346. (Pubitemid 46090506)
24. Kelley RI, Cheatham JP, Clark BJ et al. X-linked dilated cardiomyopathy with neutropenia, growth retardation, and 3-methylglutaconic aciduria. J Pediatr, 1991; 119: 738-747.
25. Chen R, Tsuji T, Ichida F et al. Mutation analysis of the G4.5 gene in patients with isolated left ventricular noncompaction. Mol Gen Metab, 2002; 77: 319-325. (Pubitemid 36027139)
26. Schmidt MR, Birkebaek N, Gonzalez I, Sunde L. Barth syndrome without 3-methylglutaconic aciduria. Acta Paediatr, 2004; 93: 419-429.
27. McCanta AC, Chang AC, Weiner K. Cardiomyopathy in a child with neutropenia and motor delay. Curr Opin Pediatr, 2008; 20: 605-607.
28. Houtkooper RH, Rodenburg RJ, Thiels C et al. Cardiolipin and monolysocardiolipin analysis in fibroblasts, lymphocytes, and tissues using high-performance liquid chromatography-mass spectrometry as a diagnostic test for Barth syndrome. Anal Biochem, 2009; 287: 230-237.
29. Rugolotto S, Prioli MD, Toniolo D et al. Long-term treatment of Barth syndrome with pantothenic acid: a retrospective study. Mol Genet Metab, 2003; 80: 408-411. (Pubitemid 37491201)
30. Mangat J, Lunnon-Wood T, Rees P et al. Succesful cardiac transplantation in Barth syndrome - single-centre experience of four patients. Pediatr Transpl, 2007; 11: 327-331. (Pubitemid 46570138)